SQZ Biotechnologies Shares Outstanding 2020-2021 | SQZ

SQZ Biotechnologies shares outstanding from 2020 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
SQZ Biotechnologies Annual Shares Outstanding
(Millions of Shares)
2020 5
2019 2
SQZ Biotechnologies Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 28
2021-03-31 26
2020-12-31 5
2020-09-30 2
2020-06-30 2
2020-03-31 2
2019-12-31
2019-09-30 2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.442B $0.021B
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29